187 related articles for article (PubMed ID: 28263922)
41. [Prophylactic effect of TLR5 agonist flagellin on acute graft versus host disease after allogeneic hematopoietic stem cell transplantation and its mechanism].
Gong XD; Ma LM; Zhu L; Guo HM; Ren LS; Ren RR; Zhang HP; Wei F; Niu YY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):965-70. PubMed ID: 22931665
[TBL] [Abstract][Full Text] [Related]
42. Plasma-based protein biomarkers can predict the risk of acute graft-versus-host disease and non-relapse mortality in patients undergoing allogeneic hematopoietic stem cell transplantation.
Shin J; Dan K; Han D; Kim JW; Kim KK; Koh Y; Shin DY; Hong J; Yoon SS; Park S; Song SH; Kim I
Blood Cells Mol Dis; 2019 Feb; 74():5-12. PubMed ID: 30344086
[TBL] [Abstract][Full Text] [Related]
43. Graft-versus-tumor effect according to type of graft-versus-host disease defined by National Institutes of Health consensus criteria and associated outcomes.
Cho BS; Lee SE; Song HH; Lee JH; Yahng SA; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
Biol Blood Marrow Transplant; 2012 Jul; 18(7):1136-43. PubMed ID: 22261380
[TBL] [Abstract][Full Text] [Related]
44. Impact of graft-versus-host disease on allogeneic hematopoietic cell transplantation for adult T cell leukemia-lymphoma focusing on preconditioning regimens: nationwide retrospective study.
Ishida T; Hishizawa M; Kato K; Tanosaki R; Fukuda T; Takatsuka Y; Eto T; Miyazaki Y; Hidaka M; Uike N; Miyamoto T; Tsudo M; Sakamaki H; Morishima Y; Suzuki R; Utsunomiya A
Biol Blood Marrow Transplant; 2013 Dec; 19(12):1731-9. PubMed ID: 24090597
[TBL] [Abstract][Full Text] [Related]
45. Higher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors.
Arpinati M; Chirumbolo G; Saunthararajah Y; Stanzani M; Bonifazi F; Bandini G; Baccarani M; Rondelli D
Biol Blood Marrow Transplant; 2007 Feb; 13(2):228-34. PubMed ID: 17241928
[TBL] [Abstract][Full Text] [Related]
46. Analysis of multipotent mesenchymal stromal cells used for acute graft-versus-host disease prophylaxis.
Kuzmina LA; Petinati NA; Shipounova IN; Sats NV; Bigildeev AE; Zezina EA; Popova MD; Drize NJ; Parovichnikova EN; Savchenko VG
Eur J Haematol; 2016 Apr; 96(4):425-34. PubMed ID: 26115424
[TBL] [Abstract][Full Text] [Related]
47. Increase of endothelial progenitor cells in acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
Medinger M; Heim D; Gerull S; Halter J; Krenger W; Buser A; Lengerke C; Bucher C; Passweg J
Leuk Res; 2016 Aug; 47():22-5. PubMed ID: 27239737
[TBL] [Abstract][Full Text] [Related]
48. CD3+/Tregs ratio in donor grafts is linked to acute graft-versus-host disease and immunologic recovery after allogeneic peripheral blood stem cell transplantation.
Pastore D; Delia M; Mestice A; Carluccio P; Perrone T; Gaudio F; Curci P; Rossi AR; Ricco A; Specchia G
Biol Blood Marrow Transplant; 2012 Jun; 18(6):887-93. PubMed ID: 22062803
[TBL] [Abstract][Full Text] [Related]
49. Composite biomarker panel for prediction of severity and diagnosis of acute GVHD with T-cell-depleted allogeneic stem cell transplants-single centre pilot study.
Min SS; Mehra V; Clay J; Cross GF; Douiri A; Dew T; Basu TN; Potter V; Ceesay MM; Pagliuca A; Sherwood RA; Vincent RP
J Clin Pathol; 2017 Oct; 70(10):886-890. PubMed ID: 28450387
[TBL] [Abstract][Full Text] [Related]
50. Immunological reconstitution and correlation of circulating serum inflammatory mediators/cytokines with the incidence of acute graft-versus-host disease during the first 100 days following unrelated umbilical cord blood transplantation.
Abu-Ghosh A; Goldman S; Slone V; van de Ven C; Suen Y; Murphy L; Sender L; Cairo M
Bone Marrow Transplant; 1999 Sep; 24(5):535-44. PubMed ID: 10482939
[TBL] [Abstract][Full Text] [Related]
51. Pentraxin-3 levels in graft-versus-host disease during allogeneic hematopoietic stem cell transplantation.
Doehn JM; Winkler A; Kuzmina Z; Hladik A; Greinix H; Knapp S; Robak O
Exp Hematol; 2016 Oct; 44(10):917-23. PubMed ID: 27403536
[TBL] [Abstract][Full Text] [Related]
52. The utility of cognitive changes in identifying those with acute graft vs. host disease following allogeneic hematopoietic cell transplant.
Stratton J; Sylvia A; Hoodin F; Choi SW; Pawarode A; Giordani B; Votruba K
Clin Neuropsychol; 2020 Jul; 34(5):969-980. PubMed ID: 31619131
[No Abstract] [Full Text] [Related]
53. IL-17-producing T cells contribute to acute graft-versus-host disease in patients undergoing unmanipulated blood and marrow transplantation.
Zhao XY; Xu LL; Lu SY; Huang XJ
Eur J Immunol; 2011 Feb; 41(2):514-26. PubMed ID: 21268020
[TBL] [Abstract][Full Text] [Related]
54. Serum microRNA181a: Correlates with the intracellular cytokine levels and a potential biomarker for acute graft-versus-host disease.
Xie L; Zhou F; Liu X; Fang Y; Yu Z; Song N; Kong F
Cytokine; 2016 Sep; 85():37-44. PubMed ID: 27288630
[TBL] [Abstract][Full Text] [Related]
55. Serum cytokine concentrations and acute graft-versus-host disease after allogeneic peripheral blood stem cell transplantation: concurrent measurement of ten cytokines and their respective ratios using cytometric bead array.
Fujii N; Hiraki A; Aoe K; Murakami T; Ikeda K; Masuda K; Matsuo K; Shinagawa K; Ishimaru F; Sugi K; Darzynkiewicz Z; Tanimoto M
Int J Mol Med; 2006 May; 17(5):881-5. PubMed ID: 16596275
[TBL] [Abstract][Full Text] [Related]
56. T cell reconstitution in allogeneic haematopoietic stem cell transplantation: prognostic significance of plasma interleukin-7.
Kielsen K; Jordan KK; Uhlving HH; Pontoppidan PL; Shamim Z; Ifversen M; Heilmann C; Nielsen CH; Sengeløv H; Ryder LP; Müller KG
Scand J Immunol; 2015 Jan; 81(1):72-80. PubMed ID: 25263171
[TBL] [Abstract][Full Text] [Related]
57. Soluble interleukin-27 receptor alpha is a valuable prognostic biomarker for acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
Liu S; Han J; Gong H; Li Y; Bao X; Qi J; Liu H; Chen J; Wu X; Xu Y; Ma S; Wu D
Sci Rep; 2018 Jul; 8(1):10328. PubMed ID: 29985424
[TBL] [Abstract][Full Text] [Related]
58. Better outcome of patients undergoing enteral tube feeding after myeloablative conditioning for allogeneic stem cell transplantation.
Seguy D; Duhamel A; Rejeb MB; Gomez E; Buhl ND; Bruno B; Cortot A; Yakoub-Agha I
Transplantation; 2012 Aug; 94(3):287-94. PubMed ID: 22785249
[TBL] [Abstract][Full Text] [Related]
59. [The relationship between cytokine mRNA expression level and acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
Zhao XS; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2010 Aug; 31(8):545-50. PubMed ID: 21122335
[TBL] [Abstract][Full Text] [Related]
60. [Relationship between CD4(+)CD25(+) regulatory T cells, IL-2, TGF-beta and acute graft-versus host disease after allogeneic hematopoietic stem cell transplantation].
Niu YY; Ma LM; Zhou Y; Ren RR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):735-9. PubMed ID: 20561440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
